InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (11 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
11
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Lewis Karen, Directeur des Ressources Humaines. Director active across 2 companies, notably Apellis Pharmaceuticals, Inc.. In total, 22 filings have been published. Breakdown: 0 buy · 11 sells. Total volume traded: €971k. History available since 21 January 2022. The latest transaction was filed on 29 January 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Lewis Karen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations22 total
364 shares@ US$29.52360.8% of flowCommon StockSEC:0001127602-25-002381:0
1,751 shares@ US$30.42553.7% of flowCommon StockSEC:0001127602-25-001839:0
1,241 shares@ US$29.95822.6% of flowCommon StockSEC:0001127602-25-001623:0
28,508 shares0Common StockSEC:0001127602-25-001623:1
1,599 shares@ US$28.70213.3% of flowCommon StockSEC:0001127602-25-001200:0
367 shares@ US$64.13821.6% of flowCommon StockSEC:0001127602-24-002743:0
4,286 shares@ US$63.6918.3% of flowCommon StockSEC:0001127602-24-002017:0
1,738 shares@ US$64.9967.6% of flowCommon StockSEC:0001127602-24-001949:0
3,276 shares@ US$65.5814.4% of flowCommon StockSEC:0001127602-24-001601:0
16,963 shares0Common StockSEC:0001127602-24-001440:0
5,000 shares@ US$34.1111.6% of flowCommon StockSEC:0001127602-23-017568:0
5,000 shares@ US$34.1111.4% of flowCommon StockSEC:0001127602-23-012595:0
1,104 shares@ US$68.765.2% of flowCommon StockSEC:0001127602-23-007326:0
6,628 shares0Common StockSEC:0000899243-23-005790:0
883 shares@ US$52.763.1% of flowCommon StockSEC:0001127602-23-002750:0
367 shares@ US$52.771.3% of flowCommon StockSEC:0001127602-23-002686:0
2,955 shares@ US$51.5810.2% of flowCommon StockSEC:0001127602-23-002179:0
1,411 shares@ US$52.054.9% of flowCommon StockSEC:0001127602-23-002132:0
1,250 shares0Common StockSEC:0001127602-23-001498:0
19,634 shares0Common StockSEC:0001127602-23-001498:1
434 shares@ US$38.59100.0% of flowCommon StockSEC:0001127602-22-002805:0
17,466 shares0Common StockSEC:0001127602-22-002059:0
22 of 22 declarations
About Lewis Karen
Lewis Karen is Chief People Officer at Apellis Pharmaceuticals, Inc. (XNAS). There are 22 filings in total, and across the 22 sampled filings between 2022-01-25 and 2025-01-30, sales total EUR 970894 and the most common transaction nature is Sell.
